New study aims to solve the puzzle of COVID-19’s long-term impact
CANCOV is a cross-Canada study that aims to understand why some people get severe disease and the long-term effects of COVID-19
Read MoreCANCOV is a cross-Canada study that aims to understand why some people get severe disease and the long-term effects of COVID-19
Read MoreTwo out of three Vancouver physicians surveyed in a new CHÉOS study faced burnout during the COVID-19 pandemic
Read MoreFeaturing some of the latest research from CHÉOS, including physician burnout during COVID-19, treating opioid use disorder, and patient perspectives on the Biosimilars Initiative
Read MoreThis edition includes major depressive disorder treatment coverage, social connections and hypertension, and paramedic experiences of the overdose response
Read MoreAfter more than 20 years at CHÉOS, Dr. Peter Dodek is set to retire at the end of June. Join us in learning about his fascinating career as a clinician-scientist
Read MoreThe latest edition summarizes some of the latest research from CHÉOS Scientists Drs. Sarah Munro, Andrea Veljkovic, Anita Palepu, Ehsan Karim, and Anne Gadermann
Read MoreThe 27th edition summarizes some of the latest research from CHÉOS Scientists, including incarceration and homelessness, adverse events, and societal values related to drug funding.
Read MorePart one of our two-part series for Patient Safety Week features research from CHÉOS Scientist Dr. Rita McCracken.
Read MoreThe twenty-third instalment of "The Evidence Speaks" Series includes the some of the latest research from CHÉOS Scientists on everything from post-operative protocols to resilience.
Read MoreRead about Dr. Nadia Khan's research that investigates chronic disease management and prevention strategies and cardiovascular risk factors related to stroke.
Read More